Skip to content
MatchScript
Menu

Head-to-head · The Match Score

CoreAge Rx vs Mixx Health & Wellness

Both scored on the same six-factor Match Score. CoreAge Rx wins this matchup with a 91 to 69 edge.

Higher Match Score

CoreAge Rx

#1 · Grade A−

Anyone who wants transparent flat pricing, fast nationwide access, and no teaser-rate bait-and-switch.

Visit CoreAge Rx
VS

Mixx Health & Wellness

#136 · Grade C

People who want low-entry compounded GLP-1 with $0 consults and a named pharmacy partner.

Visit Mixx Health & Wellness

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
82
76
Speed to Start
97
72
Formulary Match
80
40
Support Level
93
74
Flexibility
97
55
Transparency
95
94

Price, coverage & formulary

DetailCoreAge RxMixx Health & Wellness
Semaglutide$149/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageAll 50 states44 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjectable onlyInjectable only
Match Score91 · A−69 · C
Winner: CoreAge Rx

CoreAge Rx is our #1-ranked provider overall, and it takes this matchup too — a 91 Match Score to Mixx Health & Wellness's 69. The best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.

Mixx Health & Wellness is still a fair pick if its strengths line up with yours — best for: People who want low-entry compounded GLP-1 with $0 consults and a named pharmacy partner.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full CoreAge Rx reviewFull Mixx Health & Wellness review

More head-to-heads

Or browse alternatives to CoreAge Rx and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.